摘要
目的 :研究软肝冲剂对免疫性肝纤维化大鼠转化生长因子 β1(TGFβ1)和Ⅰ、Ⅲ型胶原水平的影响 ,以探讨软肝冲剂促进肝细胞再生及阻止肝纤维化、肝硬化形成的作用机制。方法 :复制免疫性肝纤维化动物模型 ,采用Rennard方法检测大鼠血清TGFβ1和Ⅰ、Ⅲ型胶原水平及肝脏组织羟脯氨酸含量。结果 :模型组大鼠血清TGFβ1和Ⅰ、Ⅲ型胶原水平及肝脏组织羟脯氨酸含量明显增加 ,与正常对照组比较 ,差异有显著性 (P <0 .0 1 ) ;中药软肝冲剂和西药秋水仙碱能明显降低免疫性肝纤维化大鼠血清TGFβ1和Ⅰ、Ⅲ型胶原水平及肝脏组织羟脯氨酸含量 ,与模型组比较 ,差异有统计学意义 (P <0 .0 5或P <0 .0 1 ) ,且中药高剂量组优于中药低剂量组和西药秋水仙碱组(P <0 .0 5或P <0 .0 1 ) ;中药低剂量组与西药秋水仙碱组比较 ,差异无显著性 (P >0 .0 5 )。结论 :软肝冲剂能明显降低免疫性肝纤维化大鼠血清TGFβ1和Ⅰ、Ⅲ型胶原水平 ,以促进肝细胞再生 ,抑制肝纤维化。
Objective:To study the influence of Ruangan Granule(RGG) on the serum levels of transforming growth factor β 1( TGFβ 1), Ⅰ and Ⅲ collagen in rats with liver fibrosis,and explore its mechanism. Method: The animal model was induced by bovine serum albumin(BSA). The serum levels of TGFβ 1, Ⅰ and Ⅲ collagen and the liver content of oxyproline hydroxyproline(Hyp) were detected according to Rennard′s methods. Result: The serum levels of TGFβ 1, Ⅰ and Ⅲ collagen and the liver content of Hyp all increased significantly in model group(P<0.01).RGG and colchicines could inhibit the above mentioned effects(P<0.05 or P<0.01), and the effects of the high dosage of RGG group were better than those of the low dosage of RGG group and colchicines group(P<0.05 or P<0.01),but there was no significant difference between the low dosage of RGG group and colchicines group(P>0.05). Conclusion: RGG can decrease the serum levels of TGFβ 1, Ⅰ and Ⅲ collagen and the liver content of Hyp ,which might contribute to its effects of anti hepatic injury, protecting hepatocytes, improving liver function ,and protecting against liver fibrosis.
出处
《安徽中医学院学报》
CAS
2004年第1期43-45,共3页
Journal of Anhui Traditional Chinese Medical College
基金
广东省中医药管理局三类新药重点资助项目(984 )